(Q42990668)

12 November 2017

Nucleic acid testing for blood banks: an experience from a tertiary care centre in New Delhi, India (English)

1 reference

12 November 2017

1 reference

N Agarwal

1

1 reference

12 November 2017

K Chatterjee

series ordinal

2

1 reference

12 November 2017

P Coshic

series ordinal

3

1 reference

12 November 2017

M Borgohain

series ordinal

4

1 reference

12 November 2017

28 March 2013

1 reference

Transfusion and Apheresis Science

12 November 2017

1 reference

12 November 2017

49

1 reference

12 November 2017

3

1 reference

12 November 2017

482-484

1 reference

Hepatitis C transmission associated with intravenous immunoglobulins.

12 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2013.03.004

Prevalence of hepatitis B virus and hepatitis C virus among blood donors at a tertiary care hospital in India: a five-year study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2013.03.004

HIV mortality and infection in India: estimates from nationally representative mortality survey of 1.1 million homes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2013.03.004

International application of the incidence rate/window period model.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2013.03.004

Current prevalence and incidence of infectious disease markers and estimated window-period risk in the American Red Cross blood donor population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2013.03.004

A new strategy for estimating risks of transfusion-transmitted viral infections based on rates of detection of recently infected donors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2013.03.004

Highly sensitive multiplex assay for detection of human immunodeficiency virus type 1 and hepatitis C virus RNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2013.03.004

Nucleic acid testing (NAT) in high prevalence-low resource settings

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2013.03.004

Housing status and HIV risk behaviors: implications for prevention and policy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2013.03.004

Detection of HIV-1 and HCV infections among antibody-negative blood donors by nucleic acid-amplification testing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2013.03.004

Experience of German Red Cross blood donor services with nucleic acid testing: results of screening more than 30 million blood donations for human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2013.03.004

The first large-scale nucleic acid amplification testing (NAT) of donated blood using multiplex reagent for simultaneous detection of HBV, HCV, and HIV-1 and significance of NAT for HBV.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2013.03.004

Two HBV DNA+/HBsAg- blood donors identified by HBV NAT in Shenzhen, China.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2013.03.004

10.1016/J.TRANSCI.2013.03.004

7 January 2021

Identifiers

DOI

1 reference

release_2sxeuqqwrfc6rm2dncisctazla

12 November 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/2sxeuqqwrfc6rm2dncisctazla

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference